Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA.
Smith J, Nazare JA, Borel AL, Aschner P, Barter PJ, Van Gaal L, Matsuzawa Y, Kadowaki T, Ross R, Brulle-Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP. Smith J, et al. Among authors: almeras n. Diabetes Obes Metab. 2013 Jul;15(7):629-41. doi: 10.1111/dom.12075. Epub 2013 Feb 24. Diabetes Obes Metab. 2013. PMID: 23356633
Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.
Borel AL, Nazare JA, Smith J, Aschner P, Barter P, Van Gaal L, Eng Tan C, Wittchen HU, Matsuzawa Y, Kadowaki T, Ross R, Brulle-Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP. Borel AL, et al. Among authors: almeras n. Int J Obes (Lond). 2015 Mar;39(3):495-501. doi: 10.1038/ijo.2014.163. Epub 2014 Sep 2. Int J Obes (Lond). 2015. PMID: 25179244
Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men.
Gangloff A, Bergeron J, Pelletier-Beaumont E, Nazare JA, Smith J, Borel AL, Lemieux I, Tremblay A, Poirier P, Alméras N, Després JP. Gangloff A, et al. Among authors: almeras n. Int J Obes (Lond). 2015 Nov;39(11):1638-43. doi: 10.1038/ijo.2015.118. Epub 2015 Jun 22. Int J Obes (Lond). 2015. PMID: 26095245
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity.
Taskinen MR, Söderlund S, Bogl LH, Hakkarainen A, Matikainen N, Pietiläinen KH, Räsänen S, Lundbom N, Björnson E, Eliasson B, Mancina RM, Romeo S, Alméras N, Pepa GD, Vetrani C, Prinster A, Annuzzi G, Rivellese A, Després JP, Borén J. Taskinen MR, et al. Among authors: almeras n. J Intern Med. 2017 Aug;282(2):187-201. doi: 10.1111/joim.12632. Epub 2017 Jun 27. J Intern Med. 2017. PMID: 28548281 Free article.
Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study.
Doucet E, St-Pierre S, Alméras N, Mauriège P, Després JP, Richard D, Bouchard C, Tremblay A; Quebec Family Study. Doucet E, et al. Among authors: almeras n. J Clin Endocrinol Metab. 2000 Nov;85(11):4231-7. doi: 10.1210/jcem.85.11.6980. J Clin Endocrinol Metab. 2000. PMID: 11095459 Clinical Trial.
Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial.
Punthakee Z, Alméras N, Després JP, Dagenais GR, Anand SS, Hunt DL, Sharma AM, Jung H, Yusuf S, Gerstein HC. Punthakee Z, et al. Among authors: almeras n. Diabet Med. 2014 Sep;31(9):1086-92. doi: 10.1111/dme.12512. Epub 2014 Jun 19. Diabet Med. 2014. PMID: 24890138 Clinical Trial.
121 results